|
|
||||||||
Eur J Cardiothorac Surg 2003;24:420-424
© 2003 Elsevier Science NL
a Department of Anaesthesiology, Akdeniz University Medical Faculty, Antalya, Turkey
b Department of Thoracic Surgery, Akdeniz University Medical Faculty, Antalya, Turkey
Received 6 March 2003; received in revised form 18 May 2003; accepted 26 May 2003.
* Corresponding author. Tel.: +90-242-227-4343; fax: +90-242-227-8836
e-mail: ayegin{at}ixir.com
| Abstract |
|---|
|
|
|---|
Key Words: Analgesia Epidural Thoracotomy Pain Postoperative
| 1. Introduction |
|---|
|
|
|---|
Although there is limited experience concerning the efficacy and safety of PCEA, initial reports suggest that it may improve analgesia, patient satisfaction and safety compared with conventional epidural infusion or bolus techniques [4,5].
Pre-emptive analgesia reduces acute postoperative pain arising from surgical wounds. It has been reported in previous studies that administration of regional anaesthesia or epidural opioid analgesia before the surgery may block the sensitising effects of surgical stimulation with a resultant reduction in subsequent acute postoperative pain [6,7].
In this study, we compared the analgesic effects of preoperative and postoperative TEA (Preop-TEA and Postop-TEA) versus Postop-TEA alone, in acute post-thoracotomy pain.
| 2. Methods |
|---|
|
|
|---|
After arrival into the operating room, all the patients were premedicated with midazolam 2 mg IV and were given 10 mL kg-1 h-1 ringer's lactate solution. Patients were monitored (Envoy; Mennen Medicals, Rehovot, Israel) with electrocardiography, pulse oximetry and non-invasive blood pressure measurements.
An 18-gauge epidural catheter (B. Braun, Melsungen, Germany) was inserted into all patients, through the T6-7 or T7-8 intervertebral space preoperatively by a midline approach with the loss of resistance technique and placed 45 cm in the cephalad direction under fluoroscopic control.
In the Preop-TEA Group, 8 mL bolus solution of 0.25% bupivacaine and 2 mL of fentanyl (25 µg mL-1) in saline was administered via the epidural catheter at least 30 min before the induction of anaesthesia. In Postop-TEA Group, no epidural medication was applied until the chest closure. All patients in both groups were dosed with 8 mL of 0.25% bupivacaine and 2 mL of fentanyl (25 µg mL-1) via the epidural route at the time of the pleural closure.
Postoperative analgesic treatment was similar and obtained with PCEA in both groups (Abbott Pain Management Provider; Abbott Laboratories, Istanbul, Turkey). PCEA was administered after extubation with an analgesic solution of 0.125% bupivacaine plus fentanyl 2 µg mL-1 according to the following program: no initial dose, basal infusion rate 4 mL h-1, bolus dose 2 mL and a 10 min lock out interval. If visual analogue scale (VAS) score at rest was higher than 4, a rescue analgesia with 5 mL bolus of PCEA solution was applied. No changes were made to the PCEA settings.
Fentanyl 2 µg kg-1, propofol 2.5 mg kg-1 and vecuronium 0.1 mg kg-1 were administered for anaesthesia induction. Patients were also monitored with invasive blood pressure and central venous pressure after the induction of anaesthesia. A double lumen tube was applied for one lung ventilation. Anaesthesia was maintained with 12% sevoflurane, 67% nitrous oxide in oxygen. Analgesia and neuromuscular blockade were maintained with incremental doses of fentanyl citrate and vecuronium bromide in the Postop-TEA Group, but fentanyl was stopped 1 h before the end of surgery to eliminate its analgesic effect during the early postoperative period. In the Preop-TEA Group, IV fentanyl was not given since it was not necessary for analgesia after the induction of anaesthesia. Patients were extubated at the end of the operation and transferred to the intensive care unit.
During the first 48 h after the operation, patients used the epidural PCA as described in the protocol and they were questioned about their pain at 2, 4, 8, 12, 24 and 48 h at rest and coughing by an observer blinded to treatment groups, using VAS (0=no pain and 10=worst pain imaginable) and the results were recorded [8].
The degree of sedation was also examined by the same observer on a five-point scale (0=alert, 1=mildly drowsy, 2=moderately drowsy, easily rousable, 3=very drowsy, rousable, 4=difficult to rouse or 5=unrousable) [9]. Side effects, including nausea, vomiting, respiratory depression, sedation and pruritus were recorded and treated with appropriate medication.
2.1. Statistical analyses
A priori power analysis indicated that a minimum of 28 patients in each group would be required to demonstrate a 10 mm difference in VAS scores for pain with a power of 83% (
=0.05) [13]. Continuous variables were analysed with two way ANOVA for repeated measurements, followed by Bonferroni correction. Differences between the groups were analysed with
2 test and MannWhitney U test (SPSS 10 for Windows, SPSS Institute, Chicago, IL). All results were presented as mean±standard deviation (SD). In all the tests, a p value less than 0.05 was regarded as significant.
| 3. Results |
|---|
|
|
|---|
|
|
|
| 4. Discussion |
|---|
|
|
|---|
In the literature, there are several studies in which the pre-emptive effect of TEA was used to reduce the post-thoracotomy pain [13,15], but in only one, it has been suggested that pre-emptive thoracic analgesia decreased pain intensity for 2 or 3 days; Obata et al. [15] showed that an epidural block with mepivacaine before surgery reduced long-term post-thoracotomy pain. This study compared the effects of pre- and postoperative initiation of TEA and found a significant clinical efficacy of pre-emptive analgesia for the first 72 h.
In contrast, some studies have found no pre-emptive effect of epidural anaesthesia in post-thoracotomy pain. Aguilar et al. [13] assessed the pre-emptive effect of thoracic epidural bupivacaine in thoracotomy. They gave 8 mL of 0.5% bupivacaine containing 5 µg mL-1 of adrenaline through a thoracic extradural catheter 30 min before incision and maintained the anaesthesia with propofol, alfentanil, and atracurium infusions. These authors reported that thoracic epidural block with bupivacaine did not produce a significant pre-emptive effect compared with the placebo group after thoracotomy. Our study has shown that the preoperative administration of bupivacaine plus fentanyl has a marked pre-emptive effect and significantly reduces post-thoracotomy pain for postoperative 12 h.
In a prospective study, Senturk et al. [16] compared the effects of preoperative and postoperative initiation of TEA and IV-PCA on acute and chronic post-thoracotomy pain and they have shown that Preop-TEA was associated with a decreased acute and chronic pain compared with the other groups. They have administered bupivacaine plus morphine in both preoperative and postoperative periods via epidural catheter. In our study, we used bupivacaine and fentanyl for PCEA and similar to Senturk et al.'s study, we found that Preop-TEA administration causes a significant decrease on the post-thoracotomy pain intensity.
Neustein et al. [6] have demonstrated that pre-emptive epidural analgesia provided lower maximum pain scores in the first 6 h postoperatively in post-thoracotomy pain. But they have not found any significant difference in pain scores beyond the first 6 h. In our study, we found that pre-emptive epidural analgesia provided lower maximum pain scores in the first 6 h, similar to Neustein's study and this decrease continued for 12 h in preoperative epidural analgesia group.
PCEA may provide several benefits over conventional epidural continuous infusion or bolus techniques. In our study, use of PCEA with bupivacaine and fentanyl provided good analgesia after thoracotomy. Previous studies have also reported effective postoperative analgesia with continuous epidural infusions of bupivacaine and morphine [17], bupivacaine and fentanyl [9], bupivacaine and sufentanil [18] and boluses of epidural morphine [19].
The ideal combination of local anaesthetic and opioid for PCEA is unknown. We selected fentanyl for its rapid onset and a relatively lower risk of delayed respiratory depression [20,21]. A 2 µg mL-1 solution of fentanyl was chosen, because previous studies demonstrated more rapid onset of action and longer duration of analgesia with similar dilution of fentanyl [20]. Other opioids may also have suitable characteristics, but epidural morphine has important disadvantages including a delayed onset of analgesia, long duration and a risk for delayed respiratory depression [22]. We also chose to add 0.125% bupivacaine to our analgesic solution, as previous dose-ranging studies suggest that the addition of approximately 0.125% bupivacaine to fentanyl improves analgesia and reduces epidural fentanyl use [20]. Use of PCEA may provide a lower incidence of side effects, by decreasing the patients requirements for analgesics such as epidural bupivacaine and fentanyl for an equivalent analgesia when compared with continuous epidural infusions [4,9,17]. Decreased use of bupivacaine and fentanyl with PCEA for an equivalent analgesia may be valuable in reducing their side effects. In our study, there was no neurological sequelae due to the thoracic epidural catheterization in the early postoperative period.
Our study has several limitations. First, in the Preop group, we administered the epidural bolus around 30 min before the induction of anaesthesia for consistency. Considering that the surgical incision was started approximately 10 min after the anaesthesia, the time between the epidural bolus and the incision was around 40 min in these patients, which is longer than that reported in the literature, and therefore, might have theoretically caused an increase in the VAS scores of the Preop group. This effect, however, is unfavorable for the Preop group, and thus, does not alter the significance of our results. Second, to eliminate its analgesic effect in the postoperative period, we stopped fentanyl administration in the Postop-TEA Group around 1 h before the end of the surgery. This interval, however, is arbitrary and probably not very consistent in each patient, since it may be difficult to predict the duration of the procedure. Third, we did not perform any testing to determine the level and the depth of the thoracic blockade, which would have been desirable. We believed, however, that because of the premedication performed with 2mg IV midazolam, this testing would not have been very accurate. Fourth, during the operation, we had to employ different analgesia regimens in both groups: in the Preop group, epidural local anaesthetic was continued, since fentanyl was regarded unnecessary and in the Postop group, IV fentanyl was used. This difference, however, is unlikely to have an effect on the postoperative VAS scores, since fentanyl was stopped 1 h before the end of the operation and local anaesthetics were given epidurally at this time simultaneously in both groups. Finally, we preferred a VAS score of 4 as the threshold value for the rescue analgesic administration, since we were concerned about the increased opioid dose after thoracic surgery in both group of patients. It is possible that if a VAS score of 3 or less had been chosen, the number of patients requiring rescue analgesia would have been different in both groups. Despite these limitations, we believe that our results are still significant, particularly considering the relatively large number of patients recruited in our study compared to those reported in the literature.
| 5. Conclusions |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Ali, D. C. Winter, A. M. Hanly, C. O'Hagan, J. Keaveny, and P. Broe Prospective, randomized, controlled trial of thoracic epidural or patient-controlled opiate analgesia on perioperative quality of life Br. J. Anaesth., February 1, 2010; (2010): aeq006v1 - aeq006. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Athanassiadi, S. Kakaris, N. Theakos, and I. Skottis Muscle-sparing versus posterolateral thoracotomy: a prospective study Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 496 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D.L. Sihoe, A. V. Manlulu, T.-W. Lee, K.-H. Thung, and A. P.C. Yim Pre-emptive local anesthesia for needlescopic video-assisted thoracic surgery: a randomized controlled trial Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 103 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Chia, T.-H. Chang, K. Liu, H.-C. Chang, N.-H. Ko, and Y.-M. Wang The Efficacy of Thoracic Epidural Neostigmine Infusion After Thoracotomy Anesth. Analg., January 1, 2006; 102(1): 201 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Fernandez, A. E. Martin-Ucar, H.D. Lee, K. J. West, R. Wyatt, and D. A. Waller Does a thoracic epidural confer any additional benefit following video-assisted thoracoscopic pleurectomy for primary spontaneous pneumothorax? Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 671 - 674. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |